Investing Profile
Stacey Seltzer
VC
Partner at Aisling Capital
Your Intro Paths to Stacey Seltzer
Signal uses Gmail to reveal intro paths. Email content is never read.
Sign in with Google →Networks Stacey is a member of
The Wharton School Network
429 CONNECTIONS
Mckinsey & Company Network
310 CONNECTIONS
Mckinsey & Company Network
310 CONNECTIONS
Mckinsey & Company Network
310 CONNECTIONS
Mckinsey & Company Network
310 CONNECTIONS
Find Stacey Seltzer on
cbStacey Seltzer is on these Sector & Stage Rankings
Stacey Seltzer's Investments On Record (2)
| Company | StageDateRound Size | Total Raised |
|---|---|---|
Aimmune Therapeutics | Series BMar 2015$80M | $80M |
Agile Therapeutics | Post Ipo EquityFeb 2015$20M Series CJul 2012$40M | $110M |
Stacey Seltzer's Experience
Business Analyst Mckinsey & CompanyPresent
Director, Business Development AkceliPresent
Director, Business Development Mckinsey & CompanyPresent
Management Associate MerckPresent
Senior Manager, Global Licensing MerckPresent
Associate Director, US Marketing MerckPresent
Principal Aisling CapitalPresent
Board Member Mckinsey & CompanyPresent
Board Member Aimmune TherapeuticsPresent
Board Member Reneo PharmaceuticalsPresent
Partner Aisling CapitalPresent
Partner Gurnet Point CapitalPresent
Managing Partner and Founder Mckinsey & CompanyPresent
Stacey Seltzer's Education
Yale University M.S. / B.S. Molecular Biophysics and Biochemistry
Wharton School of Business MBA Healthcare
The Wharton School MBA Healthcare
Investors who invest with Stacey Seltzer
Founders who looked at Stacey Seltzer's profile also looked at these Scouts & Angels